...
首页> 外文期刊>Colloids and Surfaces, A. Physicochemical and Engineering Aspects >Preparation of epirubicin-loaded poly(butyl cyanoacrylate) colloidal particles by polymerization in a mixed organic-aqueous solvent system
【24h】

Preparation of epirubicin-loaded poly(butyl cyanoacrylate) colloidal particles by polymerization in a mixed organic-aqueous solvent system

机译:在有机-水混合溶剂体系中聚合制备负载表柔比星的聚氰基丙烯酸丁酯胶体颗粒

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This article considers the preparation of poly(butyl cyanoacrylate) colloidal drug carriers loaded with the anticancer drug epirubicin by emulsion polymerization in a mixed (acetone/water) solvent system. The use of acetone as a co-solvent allowed better dispersion of the monomer in the polymerization medium and lead to the formation of more uniform nanoparticles. The epirubicin-loaded nanoparticles were prepared in acidic medium containing citric acid and different colloidal stabilizers (dextran 40, poloxamer 188). The obtained nanoparticles were characterized for morphology, size distribution, zeta-potential, drug loading efficiency, drug content, drug release rate and molecular mass distribution. It was found that the nanoparticles prepared in the presence of dextran 40 had the highest drug content, loading efficiency and colloidal stability upon storage at 4. °C as a colloidal dispersion at pH 5.5. The drug loading efficiency was decreasing, while the drug content was increasing with augmentation of the initial drug concentration. The average particle size (~250. nm) did not depend strongly on the drug concentration and was within the ranges suitable for passive tumor targeting. The zeta-potential of drug-loaded nanoparticles was slightly positive in phosphate-buffered saline (pH 7.4) in contrast to the negative zeta-potential of the respective drug-free particles. The molecular mass of polymer in the case of drug-loaded nanoparticles was larger than in the case of drug-free nanoparticles. It is expected that these results should be useful for further successful development of nanoparticle-formulated anthracyclines.
机译:本文考虑了在混合(丙酮/水)溶剂体系中通过乳液聚合制备载有抗癌药物表柔比星的聚(氰基丙烯酸丁酯)胶体药物载体。使用丙酮作为助溶剂可以使单体更好地分散在聚合介质中,并导致形成更均匀的纳米颗粒。在含有柠檬酸和不同胶体稳定剂(葡聚糖40,泊洛沙姆188)的酸性介质中制备了装载表柔比星的纳米颗粒。对所获得的纳米颗粒进行形态,尺寸分布,ζ电位,药物加载效率,药物含量,药物释放速率和分子量分布的表征。发现在葡聚糖40存在下制备的纳米颗粒在4℃下以pH 5.5的胶态分散体储存时具有最高的药物含量,负载效率和胶态稳定性。随着初始药物浓度的增加,载药效率下降,而药物含量却增加。平均粒径(〜250。nm)在很大程度上不取决于药物浓度,并且在适合被动靶向肿瘤的范围内。载有药物的纳米颗粒的Zeta电位在磷酸盐缓冲液(pH 7.4)中略微为正,而各个不含药物的颗粒的Zeta电位为负。在载有药物的纳米颗粒的情况下,聚合物的分子量大于在无药物的纳米颗粒的情况下的聚合物的分子量。预期这些结果对于进一步成功开发纳米颗粒状蒽环类药物是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号